Jaishankar meets US lawmakers, discusses Quad, cooperation on vaccines

On his 5-day visit to the US, the minister met influential American lawmakers from both Democratic and Republican parties

S Jaishankar, Jake Sullivan
During the meeting, Sullivan and Jaishankar welcomed the cooperation in recent weeks that resulted in deliveries of over USD 500 million in COVID-19 relief supplies from the US federal and state governments, US companies and private citizens
Press Trust of India Washington
2 min read Last Updated : May 28 2021 | 6:33 AM IST

External Affairs Minister S Jaishankar met influential American lawmakers from both the Democratic and Republican parties on Thursday and discussed developments pertaining to Quad and the cooperation on vaccines with them.

"Discussed developments pertaining to Quad and our cooperation on vaccines. Recognise their leadership in building stronger ties," Jaishankar said after his meeting with Congressman Gregory Meeks, who is the chairman of the powerful House Foreign Affairs Committee, along with its ranking member, Congressman Michael McCaul.

The minister also had a "good conversation" with the co-chairs of the House India Caucus, Congressman Brad Sherman from the Democratic Party and Congressman Steve Chabot from the Republican Party.

"The US Congress has been a tremendous pillar of support as India meets the Covid challenge," Jaishankar tweeted.

All the four US lawmakers have been strong advocates of the India-US relationship.

In a tweet, Sherman said he learned how India is fighting COVID-19 and working to disentangle its economy from China.

A day earlier, after introducing the Ensuring American Global Leadership and Engagement (EAGLE) Act, Congressman Meeks appreciated the Biden administration's initiative towards India.

"Secretaries Blinken and Austin's trips to Japan and Korea, and Secretary Austin's separate trip to India, so early in the new administration, reinforced America's role as a Pacific power, and signalled to China and the world that the United States is back in the arena with our allies and partners alongside us," he said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusS JaishankarQuadCoronavirus Vaccine

First Published: May 28 2021 | 6:29 AM IST

Next Story